Addex Therapeutics Ltd. (ADXN)
4.02
+0.12
(+3.08%)
USD |
NASDAQ |
Aug 26, 10:34
Addex Therapeutics Debt to Equity Ratio : 0.0311 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.0311 |
| December 31, 2025 | 0.0073 |
| September 30, 2025 | 0.0061 |
| June 30, 2025 | 0.0053 |
| March 31, 2025 | 0.0048 |
| December 31, 2024 | 0.0043 |
| September 30, 2024 | 0.004 |
| June 30, 2024 | 0.0025 |
| March 31, 2024 | -0.0256 |
| December 31, 2023 | 0.3008 |
| September 30, 2023 | 0.082 |
| June 30, 2023 | 0.0381 |
| March 31, 2023 | 0.0637 |
| December 31, 2022 | 0.076 |
| September 30, 2022 | 0.0562 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.0491 |
| March 31, 2022 | 0.0319 |
| December 31, 2021 | 0.0285 |
| September 30, 2021 | 0.0391 |
| June 30, 2021 | 0.0256 |
| March 31, 2021 | 0.0237 |
| December 31, 2020 | 0.039 |
| September 30, 2020 | 0.0171 |
| June 30, 2020 | 0.0194 |
| March 31, 2020 | 0.0211 |
| December 31, 2007 | 0.00 |
| June 30, 2007 | 0.0004 |
| March 31, 2007 | 0.0027 |
| December 31, 2006 | 0.003 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Novartis AG | 1.180 |
| Roche Holding AG | -- |
| Oculis Holding AG | 0.0116 |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.920M |
| Total Liabilities (Quarterly) | 1.832M |
| Shareholders Equity (Quarterly) | 4.087M |
| Current Ratio | 0.9715 |
| Net Debt Paydown Yield | -0.26% |